Changsha Municipal Center for Disease Control and Prevention, Changsha, China.
Key Laboratory for Prevention and Control of Avian Influenza and Other Major Poultry Diseases, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Lancet Microbe. 2022 Nov;3(11):e824-e834. doi: 10.1016/S2666-5247(22)00192-6. Epub 2022 Sep 14.
The H3N8 avian influenza virus (AIV) has been circulating in wild birds, with occasional interspecies transmission to mammals. The first human infection of H3N8 subtype occurred in Henan Province, China, in April, 2022. We aimed to investigate clinical, epidemiological, and virological data related to a second case identified soon afterwards in Hunan Province, China.
We analysed clinical, epidemiological, and virological data for a 5-year-old boy diagnosed with H3N8 AIV infection in May, 2022, during influenza-like illness surveillance in Changsha City, Hunan Province, China. H3N8 virus strains from chicken flocks from January, 2021, to April, 2022, were retrospectively investigated in China. The genomes of the viruses were sequenced for phylogenetic analysis of all the eight gene segments. We evaluated the receptor-binding properties of the H3N8 viruses by using a solid-phase binding assay. We used sequence alignment and homology-modelling methods to study the effect of specific mutations on the human receptor-binding properties. We also conducted serological surveillance to detect the H3N8 infections among poultry workers in the two provinces with H3N8 cases.
The clinical symptoms of the patient were mild, including fever, sore throat, chills, and a runny nose. The patient's fever subsided on the same day of hospitalisation, and these symptoms disappeared 7 days later, presenting mild influenza symptoms, with no pneumonia. An H3N8 virus was isolated from the patient's throat swab specimen. The novel H3N8 virus causing human infection was first detected in a chicken farm in Guangdong Province in December, 2021, and subsequently emerged in several provinces. Sequence analyses revealed the novel H3N8 AIVs originated from multiple reassortment events. The haemagglutinin gene could have originated from H3Ny AIVs of duck origin. The neuraminidase gene belongs to North American lineage, and might have originated in Alaska (USA) and been transferred by migratory birds along the east Asian flyway. The six internal genes had originated from G57 genotype H9N2 AIVs that were endemic in chicken flocks. Reassortment events might have occurred in domestic ducks or chickens in the Pearl River Delta area in southern China. The novel H3N8 viruses possess the ability to bind to both avian-type and human-type sialic acid receptors, which pose a threat to human health. No poultry worker in our study was positive for antibodies against the H3N8 virus.
The novel H3N8 virus that caused human infection had originated from chickens, a typical spillover. The virus is a triple reassortment strain with the Eurasian avian H3 gene, North American avian N8 gene, and dynamic internal genes of the H9N2 viruses. The virus already possesses binding ability to human-type receptors, though the risk of the H3N8 virus infection in humans was low, and the cases are rare and sporadic at present. Considering the pandemic potential, comprehensive surveillance of the H3N8 virus in poultry flocks and the environment is imperative, and poultry-to-human transmission should be closely monitored.
National Natural Science Foundation of China, National Key Research and Development Program of China, Strategic Priority Research Program of the Chinese Academy of Sciences, Hunan Provincial Innovative Construction Special Fund: Emergency response to COVID-19 outbreak, Scientific Research Fund of Hunan Provincial Health Department, and the Hunan Provincial Health Commission Foundation.
H3N8 禽流感病毒(AIV)一直在野生鸟类中传播,偶尔会发生种间传播给哺乳动物。首例人类感染 H3N8 亚型病毒发生在中国河南省,时间为 2022 年 4 月。我们旨在调查与随后在中国湖南省发现的第二例病例相关的临床、流行病学和病毒学数据。
我们分析了 2022 年 5 月在中国湖南省长沙市流感样疾病监测期间,一名 5 岁男孩确诊感染 H3N8 AIV 的临床、流行病学和病毒学数据。我们回顾性调查了 2021 年 1 月至 2022 年 4 月期间中国鸡群中的 H3N8 病毒株。对所有 8 个基因片段的病毒基因组进行了测序,以进行系统进化分析。我们使用固相结合测定法评估 H3N8 病毒的受体结合特性。我们使用序列比对和同源建模方法研究了特定突变对人类受体结合特性的影响。我们还进行了血清学监测,以检测两省 H3N8 病例中家禽工人的 H3N8 感染情况。
患者的临床症状较轻,包括发热、咽痛、寒战和流鼻涕。患者的发热在住院当天消退,这些症状在 7 天后消失,表现出轻度流感症状,无肺炎。从患者的咽喉拭子标本中分离出 H3N8 病毒。引起人类感染的新型 H3N8 病毒于 2021 年 12 月首次在广东省的一个鸡场中检测到,随后在多个省份出现。序列分析显示,新型 H3N8 AIV 源自多次重组事件。血凝素基因可能源自鸭源 H3Ny AIV。神经氨酸酶基因属于北美谱系,可能起源于美国阿拉斯加,并通过沿东亚迁徙路线的候鸟传播。6 个内部基因源自 G57 基因型 H9N2 AIV,该病毒在鸡群中流行。重组事件可能发生在中国南部珠江三角洲地区的家鸭或家鸡中。新型 H3N8 病毒具有结合禽型和人型唾液酸受体的能力,这对人类健康构成威胁。我们的研究中没有家禽工人对 H3N8 病毒的抗体呈阳性。
导致人类感染的新型 H3N8 病毒源自鸡,这是一种典型的溢出事件。该病毒是一种三重重组株,具有欧亚禽源性 H3 基因、北美禽源性 N8 基因和 H9N2 病毒的动态内部基因。该病毒已经具有结合人型受体的能力,尽管 H3N8 病毒感染人类的风险较低,目前病例罕见且呈散发性。考虑到大流行的潜力,有必要对禽类和环境中的 H3N8 病毒进行全面监测,并密切监测禽类向人类的传播。
国家自然科学基金、国家重点研发计划、中国科学院战略重点研究计划、湖南省创新建设专项资金:应对 COVID-19 疫情、湖南省卫生健康委科学研究基金和湖南省卫生健康委员会基金。